Pesquisar





Pesquisar





Mercados
/
Ações
/
nasdaq-dva
/

DaVita Inc

DVA

Adicionar à lista de desejos

198.650USD

+2.410+1.23%

Fechamento 05/08, 16:00（ET）Cotações atrasadas em 15 min

12.75BValor de mercado

18.16P/L TTM



DaVita Inc

198.650

+2.410+1.23%

Visão Geral Serviços Financeiros Análises Empresa

Visão Geral

Serviços Financeiros

Análises

Empresa

Mais detalhes de DaVita Inc Empresa

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Informações de DaVita Inc



Código da empresaDVA

Nome da EmpresaDaVita Inc

Data de listagemOct 31, 1995

CEORodriguez (Javier J)

Número de funcionários76000

Tipo de títulosOrdinary Share

Fim do ano fiscalOct 31

Endereço2000 16th St

CidadeDENVER

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal80202-5117

Telefone13105362668

Sitehttps://www.davita.com/

Código da empresaDVA

Data de listagemOct 31, 1995

CEORodriguez (Javier J)

Executivos da empresa DaVita Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

845.14K

+1.48%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

161.55K

+33.27%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

106.29K

+35.70%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

47.08K

+72.21%

Mr. James O. Hearty

Chief Compliance Officer

31.27K

+53.52%

Ms. Pamela M. Arway

Independent Chair of the Board

26.70K

+1.24%

Mr. Christopher Michael (Chris) Berry

Chief Accounting Officer

19.61K

+18.61%

Ms. Phyllis R. Yale

Independent Director

14.31K

+2.32%

Ms. Barbara J. Desoer

Independent Director

13.77K

+2.41%

Dr. Gregory J. Moore, M.D., Ph.D.

Independent Director

7.56K

+4.39%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Javier J. Rodriguez

Chief Executive Officer, Director

845.14K

+1.48%

Mr. Joel Ackerman

Chief Financial Officer, Treasurer

161.55K

+33.27%

Ms. Kathleen Alyce Waters

Chief Legal and Public Affairs Officer

106.29K

+35.70%

Mr. David P. Maughan

Chief Operating Officer - Davita Kidney Care

47.08K

+72.21%

Mr. James O. Hearty

Chief Compliance Officer

31.27K

+53.52%

Ms. Pamela M. Arway

Independent Chair of the Board

26.70K

+1.24%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Patient service - Medicare and Medicare Advantage

6.74B

49.41%

Patient service - Commercial

4.19B

30.73%

Patient service - Other government

1.26B

9.27%

Patient service - Medicaid and Managed Medicaid

871.70M

6.39%

Other - Medicare and Medicare Advantage

507.61M

3.72%

Outro

67.31M

0.49%

Os dados relevantes ainda não foram divulgados pela empresa.

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Patient service - Medicare and Medicare Advantage

6.74B

49.41%

Patient service - Commercial

4.19B

30.73%

Patient service - Other government

1.26B

9.27%

Patient service - Medicaid and Managed Medicaid

871.70M

6.39%

Other - Medicare and Medicare Advantage

507.61M

3.72%

Outro

67.31M

0.49%

Distribuição de ações

Atualizado em: há 7 horas

Investidores

Tipos de investidores

Investidores

Proporção

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

6.29%

BlackRock Institutional Trust Company, N.A.

3.42%

Weschler (R Ted)

3.40%

Vanguard Capital Management, LLC

3.40%

Outro

38.51%

Investidores

Proporção

Berkshire Hathaway Inc.

44.98%

The Vanguard Group, Inc.

6.29%

BlackRock Institutional Trust Company, N.A.

3.42%

Weschler (R Ted)

3.40%

Vanguard Capital Management, LLC

3.40%

Outro

38.51%

Tipos de investidores

Investidores

Proporção

Holding Company

44.99%

Investment Advisor

31.98%

Investment Advisor/Hedge Fund

15.56%

Hedge Fund

8.34%

Individual Investor

5.70%

Research Firm

3.59%

Pension Fund

1.20%

Sovereign Wealth Fund

0.67%

Bank and Trust

0.65%

Participação acionária institucional



Atualizado em: dom, 5 de abr

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2026Q1

1310

36.02M

56.10%

-3.26M

2025Q4

1268

36.29M

57.41%

+15.99K

2025Q3

1299

36.28M

57.59%

-1.47M

2025Q2

1288

37.75M

54.27%

+725.11K

2025Q1

1275

37.24M

54.43%

-4.83M

2024Q4

1234

39.31M

53.45%

-1.10M

2024Q3

1192

40.91M

54.63%

-1.68M

2024Q2

1162

42.62M

55.55%

-1.85M

2024Q1

1146

44.41M

55.70%

-4.44M

2023Q4

1143

45.66M

55.03%

+259.36K

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Berkshire Hathaway Inc.

30.10M

43.91%

-1.66M

-5.22%

Jan 29, 2026

The Vanguard Group, Inc.

4.14M

6.2%

-64.89K

-1.54%

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

2.19M

3.28%

-202.51K

-8.45%

Dec 31, 2025

Weschler (R Ted)

2.18M

3.27%

Aug 06, 2024

Invesco Capital Management LLC

1.51M

2.27%

+114.35K

+8.17%

Dec 31, 2025

State Street Investment Management (US)

1.44M

2.15%

-396.34K

-21.60%

Dec 31, 2025

Arrowstreet Capital, Limited Partnership

1.19M

1.78%

+636.19K

+114.88%

Dec 31, 2025

Gates Capital Management, Inc.

1.18M

1.76%

-14.90K

-1.25%

Dec 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

Aztlan Global Stock Selection DM SMID ETF

2.59%

State Street SPDR S&P Health Care Services ETF

1.84%

Strategas Global Policy Opportunities ETF

1.64%

Invesco S&P 500 Equal Weight Health Care ETF

1.47%

Pacer US Cash Cows Growth ETF

1.02%

AdvisorShares Insider Advantage ETF

0.95%

Global X Aging Population ETF

0.75%

iShares U.S. Healthcare Providers ETF

0.67%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

0.67%

LeaderShares AlphaFactor US Core ETF

0.66%

Ver Mais

Aztlan Global Stock Selection DM SMID ETF

Proporção2.59%

State Street SPDR S&P Health Care Services ETF

Proporção1.84%

Strategas Global Policy Opportunities ETF

Proporção1.64%

Invesco S&P 500 Equal Weight Health Care ETF

Proporção1.47%

Pacer US Cash Cows Growth ETF

Proporção1.02%

AdvisorShares Insider Advantage ETF

Proporção0.95%

Global X Aging Population ETF

Proporção0.75%

iShares U.S. Healthcare Providers ETF

Proporção0.67%

Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx

Proporção0.67%

LeaderShares AlphaFactor US Core ETF

Proporção0.66%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados

KeyAI

